We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Peripheral IV Cannulas Linked to Higher Phlebitis Rates

By HospiMedica International staff writers
Posted on 15 Jan 2019
The incidence of phlebitis caused by peripheral intravenous (IV) cannula insertions may be higher among patients with certain risk factors, claims a new study.

Researchers at the University of Novi Sad (Serbia) conducted an observational study that prospectively observed 1,428 peripheral IV cannula insertions in 368 adult hospitalized inpatients at Novi Sad health care clinics. More...
Data collected included patients’ medical information; data related to each cannula insertion, including placement, monitoring, and the reasons for removal; and administered medications and solutions. The results revealed that phlebitis ranked first among complications with an occurrence of 44%, followed by infiltration (16.3%), occlusion (7.6%), and catheter dislodgement (5.6%).

The results showed that the risk for phlebitis was higher with comorbidities, current infection, catheter size, time in situ, and the total number of infusion solutions administered. Infiltration risk also increased with 20-gauge catheters, two or more attempts at cannulation, and administration of high-risk solutions during the first day of hospitalization. The most common individual complications were medium stage phlebitis and grade two infiltrations. The study was published on December 27, 2018, in the Journal of Clinical Nursing.

“Incidence of infiltration, occlusion, and dislodgment is almost congruent with the average incidence of previous studies. However, the incidence and degree of severity associated with the occurrence of phlebitis were significantly higher,” concluded lead author Dragana Simin, PhD, RN, of the department of nursing, and colleagues.

Phlebitis and thrombosis of superficial veins in the legs (also known as superficial thrombophlebitis) is generally a benign, self-limited disorder; however, when the larger axial veins are involved, such as in superficial vein thrombosis (SVT), propagation into the deep vein system can occur, resulting in deep vein thrombosis (DVT), and even pulmonary embolism. Treatment is aimed at relieving local symptoms and preventing thromboembolic complications.

Related Links:
University of Novi Sad


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.